Ernexa Therapeutics Inc.

NasdaqCM: ERNA · Healthcare

Positivity Index

#1,549 / 6,774

Global

#353 / 4,000

United States

Positivity Score

22,598

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 20 Mar 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Ernexa Therapeutics Inc. — Overview & Financial Snapshot

Ernexa Therapeutics Inc. (NasdaqCM: ERNA) is a Healthcare company, ranked #1,549 of 6,774 companies globally and #353 of 4,000 in United States on PositoAI, with a Positivity Score of 22,598. Its market capitalisation is ₹31.97 Cr ($3.39M), P/E ratio is -0.2 and P/B ratio is 1.06. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Ernexa Therapeutics Inc. do?

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of…

What is Ernexa Therapeutics Inc.'s P/E and P/B ratio?

Ernexa Therapeutics Inc. has a P/E ratio of -0.2 and a P/B ratio of 1.06.

What is Ernexa Therapeutics Inc.'s debt-to-equity ratio?

Ernexa Therapeutics Inc. has a debt-to-equity ratio of 0.11.

How much does Ernexa Therapeutics Inc. owe compared with what it owns?

Ernexa Therapeutics Inc. owes $0.49 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Ernexa Therapeutics Inc.'s Positivity rank?

Ernexa Therapeutics Inc. is ranked #1,549 of 6,774 companies globally and #353 of 4,000 in United States on PositoAI, with a Positivity Score of 22,598.

Does Ernexa Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Ernexa Therapeutics Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 20 Mar 2026). It has no yellow flags.

Where can I read the latest news about Ernexa Therapeutics Inc.?

Recent headlines about Ernexa Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Ernexa Therapeutics Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Ernexa Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.